pharmaceuticals « Science and Enterprise

Trial Shows Vaccine Induces Chikungunya Immune Response

By Alan, on August 7th, 2023%

Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients. . . . → Read More: Trial Shows Vaccine Induces Chikungunya Immune Response

Long-Acting Drug Start-Up Raises $4M in Seed Funds

By Alan, on August 4th, 2023%

A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds. . . . → Read More: Long-Acting Drug Start-Up Raises $4M in Seed Funds

Trial Advances of Dual-Action Cancer Immunotherapy

By Alan, on August 3rd, 2023%

A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study. . . . → Read More: Trial Advances of Dual-Action Cancer Immunotherapy

Digital Chemistry Start-Up Gains $43M in Early Funds

By Alan, on August 2nd, 2023%

A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds

Companies Partner on Fast Production of Biologics in Plants

By Alan, on August 1st, 2023%

The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities. . . . → Read More: Companies Partner on Fast Production of Biologics in Plants

Streamlined Gene Therapy Delivery Process Demonstrated

By Alan, on July 27th, 2023%

A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive. . . . → Read More: Streamlined Gene Therapy Delivery Process Demonstrated

Trial Cleared for Lab-Grown Replacement Knee Cartilage

By Alan, on July 25th, 2023%

A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage

Cancer Immunotherapy Biotech Issues $80M IPO

By Alan, on July 21st, 2023%

A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO

One-Time Crispr HIV Therapy Given Fast-Track Status

By Alan, on July 20th, 2023%

A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status

Darpa Seeking On-Demand, Distributed Production of Proteins

By Alan, on July 19th, 2023%

Aerial view of the Pentagon in Washington, D.C.

A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise